Ophthalmology News and Research

RSS

Ophthalmology is the specialized field of medicine that focuses on the health of the eye. It includes the anatomy, physiology and diseases that may affect the eye. Historically, the science of ophthalmology encompassed all aspects of visual function, both in health and in illness. Additionally, ophthalmology also includes animal eyes as ocular function and optic diseases are similar among humans and animals.

ACGME task force presents draft standards that revise requirements for better supervision, duty hours

The Accreditation Council for Graduate Medical Education task force charged with reassessing resident training program standards today presented a comprehensive set of draft standards that revise requirements for supervision and duty hours to better match residents' levels of experience and emerging competencies, advancing both graduate medical education and quality patient care in the nation's teaching hospitals.

24 Jun 2010

FDA cancels Advisory Committee review of Lux Biosciences' voclosporin NDA

Isotechnika Pharma Inc. today announced that the U.S. Food and Drug Administration (FDA) has cancelled the Dermatology and Ophthalmology Drugs Advisory Committee review of partner, Lux Biosciences', New Drug Application (NDA) for voclosporin on June 28, 2010.

24 Jun 2010

QLT reports final 24-month results from Phase II RADICAL study in patients with wet AMD

QLT Inc. today announced final 24-month results from the Phase II RADICAL study (Reduced Fluence Visudyne Anti-VEGF-Dexamethasone In Combination for AMD Lesions) in patients with exudative (wet) age-related macular degeneration. The purpose of the study was to determine if Visudyne® combined with Lucentis® reduced retreatment rates compared with Lucentis monotherapy, while maintaining similar vision outcomes and an acceptable safety profile.

22 Jun 2010

OXiGENE reports encouraging data from ZYBRESTAT program at Glaucoma and Retinopathies 2010 conference

OXiGENE, Inc., a clinical-stage, biopharmaceutical company developing novel therapeutics to treat cancer and eye diseases, announced today that the company presented an update on its ZYBRESTAT ophthalmology program, including encouraging preclinical data showing that the company's topical formulation achieved target retina/choroid concentrations with minimal systemic exposure.

22 Jun 2010

Blind cyclists to travel from Toronto to Collingwood in support of the Foundation Fighting Blindness

On Saturday, June 19th, the vision impaired community will team up with cycling enthusiasts to embark on a 140 km journey for second annual Cycle for Sight, in support of the Foundation Fighting Blindness.

19 Jun 2010

National Cheng Kung University Hospital's Outpatient Building inaugurated

The Outpatient Building of National Cheng Kung University Hospital was officially inaugurated on June 12th to provide excellent medical service and to further ensure the health of people in Southern Taiwan.

18 Jun 2010

WTA report card: Many Canadian patients still face long waits for needed medical care

A Wait Time Alliance report card released today reveals troubling wait time hot spots in the five clinical areas deemed priorities by governments and more problems across a broader range of medical care.

18 Jun 2010

UMHHC expects to achieve 3.3% operating margin on revenues of $2.0 billion in fiscal year 2010

The Hospitals and Health Centers unit of the University of Michigan Health System will finish its fiscal year in strong financial shape, with a positive operating margin nearly twice the size predicted a year ago.

18 Jun 2010

Researchers use computer-based model to study human visual intelligence

Scientists have just come several steps closer to understanding change blindness - the well studied failure of humans to detect seemingly obvious changes to scenes around them - with new research that used a computer-based model to predict what types of changes people are more likely to notice.

17 Jun 2010

Lantis Laser to merge with Perio-Imaging

Lantis Laser Inc., announced today that it has signed a Letter of Intent to merge with Perio-Imaging Inc., a private New York based company. The merger would be an all stock transaction and closing, among other conditions, would be subject to raising the required funding to complete the proposed merged company's product development program. The name of the new merged company will be announced upon closing.

16 Jun 2010

Final results from Visudyne Phase IIIb DENALI study presented at World Ophthalmology Congress

QLT Inc. today announced that final results from the Novartis-sponsored Phase IIIb DENALI study were presented on June 8, 2010 during the World Ophthalmology Congress in Berlin. DENALI was a 24-month randomized, double-masked, multicenter trial in patients with subfoveal choroidal neovascularization secondary to wet age-related macular degeneration (all lesion types).

16 Jun 2010

Peter and Patricia Gruber Foundation to present 2010 Neuroscience Prize to Robert H. Wurtz

Robert H. Wurtz, PhD, a pioneer and leader in the field of neurophysiology, is the recipient of the 2010 Neuroscience Prize of The Peter and Patricia Gruber Foundation. His discoveries of how the brain processes visual information and controls eye movements laid the groundwork for subsequent research into the neurophysiology of visual cognition. This research has led scientists to a deeper understanding of how the brain is organized to produce behavior.

15 Jun 2010

Equatorial Guinea advances public health services with ultramodern hospital in Bata

Equatorial Guinea (Republica de Guinea Ecuatorial) is advancing its public health services with an ultramodern hospital in Bata, the country's most populous city. One of the most sophisticated hospitals in West Africa, La Paz Medical Center operates in complete compliance with international standards and employs highly advanced technology systems.

11 Jun 2010

Synteract joins Medidata's ASPire to Win channel partner program

Medidata Solutions, a leading global provider of SaaS-based clinical development solutions, today announced that Synteract has joined Medidata's ASPire to Win® channel partner program. A full-service contract research organization (CRO) with an increasing global presence and extensive experience working with emerging biotech, pharmaceutical and medical device sponsors, Synteract will offer services around Medidata Rave®, the market-leading electronic data capture (EDC) and clinical data management (CDM) solution.

9 Jun 2010

Better understanding of eye movements can help develop strategies for reducing crash risks: Study

More than 16 people are killed and more than 1,300 people are injured each day in crashes involving a distracted driver, a phenomenon that could be reduced with the right application of motion information and appropriate eye movements.

9 Jun 2010

RoundTable signs agreement to acquire Ophthalmic Systems business unit

RoundTable Healthcare Partners, an operating-oriented private equity firm focused exclusively on the health-care industry, announced today that is has entered into an agreement with BD to acquire the Ophthalmic Systems unit, a business within the BD Medical segment. BD is a leading global medical technology company that develops, manufactures and sells medical devices, instrument systems and reagents.

9 Jun 2010

TG-MV-006 study: Microplasmin shows promise for treatment of VMA, MH

A Phase III trial of a drug used for the treatment of vitreomacular adhesion and macular hole revealed key findings for patients diagnosed with these severe conditions which can lead to significant vision impairment.

8 Jun 2010

Optical coherence tomography shows promise for multiple sclerosis diagnosis

A quick, painless eye measurement shows promise as a way to diagnose multiple sclerosis in its very early stages, and to track the effectiveness of treatments, researchers from UT Southwestern Medical Center have found in a multicenter study.

8 Jun 2010

Ranibizumab improves vision in patients with visual impairment due to DME: RESTORE study

Results from a new major diabetes eye health study may have the potential to change the way vision loss due to diabetic macular edema, a serious and devastating complication of diabetes, is treated. One year results from the RESTORE study show that 37 per cent of patients treated with ranibizumab only and 43 per cent of those treated with ranibizumab plus laser therapy, had a significant improvement in visual acuity of 10 letters or more on an eye chart, compared to 16 per cent of patients treated with laser alone - the current standard treatment for visual impairment due to DME.

7 Jun 2010

Microplasmin exhibits potential to cure 50% of patients with macular hole

ThromboGenics NV, a biopharmaceutical company focused on the discovery and development of innovative treatments for eye disease, announces that further data from the first successful Phase III trial with microplasmin (TG-MV-006) for the non-surgical treatment of vitreomacular adhesion (VMA) were presented at the World Ophthalmology Congress by Dr. Matthew Benz, MD (The Methodist Hospital, Houston, Texas, U.S.)

7 Jun 2010

Ophthalmology News and Research

Further Reading

ACGME task force presents draft standards that revise requirements for better supervision, duty hours

FDA cancels Advisory Committee review of Lux Biosciences' voclosporin NDA

QLT reports final 24-month results from Phase II RADICAL study in patients with wet AMD

OXiGENE reports encouraging data from ZYBRESTAT program at Glaucoma and Retinopathies 2010 conference

Blind cyclists to travel from Toronto to Collingwood in support of the Foundation Fighting Blindness

National Cheng Kung University Hospital's Outpatient Building inaugurated

WTA report card: Many Canadian patients still face long waits for needed medical care

UMHHC expects to achieve 3.3% operating margin on revenues of $2.0 billion in fiscal year 2010

Researchers use computer-based model to study human visual intelligence

Lantis Laser to merge with Perio-Imaging

Final results from Visudyne Phase IIIb DENALI study presented at World Ophthalmology Congress

Peter and Patricia Gruber Foundation to present 2010 Neuroscience Prize to Robert H. Wurtz

Equatorial Guinea advances public health services with ultramodern hospital in Bata

Synteract joins Medidata's ASPire to Win channel partner program

Better understanding of eye movements can help develop strategies for reducing crash risks: Study

RoundTable signs agreement to acquire Ophthalmic Systems business unit

TG-MV-006 study: Microplasmin shows promise for treatment of VMA, MH

Optical coherence tomography shows promise for multiple sclerosis diagnosis

Ranibizumab improves vision in patients with visual impairment due to DME: RESTORE study

Microplasmin exhibits potential to cure 50% of patients with macular hole

Achieving and maintaining ISO/IEC 27001 and BS 10012 certifications

Expanding research and clinical options for children with cancer

Examining how pain could play a direct protective role in the gut

Latest News